EIB signs collaboration with Israel Innovation Authority and Euro50 million financing agreement with Pluristem to develop therapies for COVID-19 and other unmet medical needs
Stock Information for Pluristem Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.